SANDOZ GEFITINIB
SANDOZ CANADA INCORPORATED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is SANDOZ GEFITINIB discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that SANDOZ GEFITINIB 250MG has been permanently discontinued (last updated November 18, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is SANDOZ GEFITINIB not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
IRESSA
ASTRAZENECA CANADA INC
APO-GEFITINIB
APOTEX INC
EUGIA-GEFITINIB
EUGIA PHARMA INC.
AURO-GEFITINIB
AURO PHARMA INC
JAMP GEFITINIB
JAMP PHARMA CORPORATION
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02487748
Strength
250MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
GEFITINIB
Tier
Unrated
Last Updated
2025-11-18
Reason for Shortage
Business reasons
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495910
DIN 02495937
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759